Cargando…

Elevated CD36 expression correlates with increased visceral adipose tissue and predicts poor prognosis in ccRCC patients

Objective: Growing evidence has proved obesity one of the confirmed important etiologic indicators for renal cell carcinoma (RCC). CD36 is underpinned to be involved in adipose absorption, but its role in clear cell renal cell carcinoma (ccRCC) remains unclear. This study aimed to investigate the mR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Wen-Hao, Qu, Yuan-Yuan, Wang, Jun, Wang, Hong-Kai, Wan, Fang-Ning, Zhao, Jian-Yuan, Zhang, Hai-Liang, Ye, Ding-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746135/ https://www.ncbi.nlm.nih.gov/pubmed/31528216 http://dx.doi.org/10.7150/jca.30989

Ejemplares similares

CD44 Is Associated with Poor Prognosis of ccRCC and Facilitates ccRCC Cell Migration and Invasion through HAS1/MMP9
por: Du, Tan, et al.
Publicado: (2023)

Untangling ccRCC prognosis with SLINKY
por: Reinfeld, Bradley I., et al.
Publicado: (2017)

Identification of key genes of the ccRCC subtype with poor prognosis
por: Puzanov, Grigory Andreevich
Publicado: (2022)

Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC
por: Ribback, Silvia, et al.
Publicado: (2021)

CD103+ Tissue Resident T-Lymphocytes Accumulate in Lung Metastases and Are Correlated with Poor Prognosis in ccRCC
por: Sanders, Christine, et al.
Publicado: (2022)

MT1X is an oncogene and indicates prognosis in ccRCC
por: Ding, Yanpeng, et al.
Publicado: (2022)

Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC: CPT1A inhibits ccRCC cell proliferation via PPARα/CD36 axis
por: Yang, Hui, et al.
Publicado: (2021)

Functional and translational consequences of immunometabolic coevolution in ccRCC
por: Reznik, Ed, et al.
Publicado: (2023)

Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database
por: Wan, Bangbei, et al.
Publicado: (2020)

CD146 as a Prognostic-Related Biomarker in ccRCC Correlating With Immune Infiltrates
por: Lv, Zheng, et al.
Publicado: (2021)

Pivotal biomarker expression and drug screening in advanced ccRCC
por: Xiao, Wen, et al.
Publicado: (2020)

SDHB Suppresses the Tumorigenesis and Development of ccRCC by Inhibiting Glycolysis
por: Fang, Zhiyu, et al.
Publicado: (2021)

Cuproptosis in ccRCC: key player in therapeutic and prognostic targets
por: Lv, Yang, et al.
Publicado: (2023)

The Downregulation of Prognosis- and Immune Infiltration-Related Gene CYFIP2 Serves as a Novel Target in ccRCC
por: Tong, Junwei, et al.
Publicado: (2021)

Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC
por: Xue, Wei, et al.
Publicado: (2023)

PLK4 Is a Potential Biomarker for Abnormal Tumor Proliferation, Immune Infiltration, and Prognosis in ccRCC
por: Hu, Chenglu, et al.
Publicado: (2022)

Does the Urinary Proteome Reflect ccRCC Stage and Grade Progression?
por: Santorelli, Lucia, et al.
Publicado: (2021)

A multiomics disease progression signature of low-risk ccRCC
por: Strauss, Philipp, et al.
Publicado: (2022)

Bioinformatics Analysis of Prognostic Value of SPC24 in ccRCC and Pan-Cancer
por: Zhang, Jipeng, et al.
Publicado: (2022)

Identification of FDFT1 as a potential biomarker associated with ferroptosis in ccRCC
por: Huang, Ruizhen, et al.
Publicado: (2022)

Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC
por: Ma, Jing, et al.
Publicado: (2020)

High GTSE1 expression promotes cell proliferation, metastasis and cisplatin resistance in ccRCC and is associated with immune infiltrates and poor prognosis
por: Lei, Pu, et al.
Publicado: (2023)

Identification of AKI signatures and classification patterns in ccRCC based on machine learning
por: Wang, Li, et al.
Publicado: (2023)

Role of copper ionophore–induced death in immune microenvironment and clinical prognosis of ccRCC: An integrated analysis
por: Xia, Shunyao, et al.
Publicado: (2022)

A novel thinking: DDR axis refines the classification of ccRCC with distinctive prognosis, multi omics landscape and management strategy
por: Jiang, Aimin, et al.
Publicado: (2022)

Transcription Factor and miRNA Interplays Can Manifest the Survival of ccRCC Patients
por: Qin, Shijie, et al.
Publicado: (2019)

LRG1 May Accelerate the Progression of ccRCC via the TGF-β Pathway
por: Hong, Quan, et al.
Publicado: (2020)

SCD5 Regulation by VHL Affects Cell Proliferation and Lipid Homeostasis in ccRCC
por: Ganner, Athina, et al.
Publicado: (2023)

A Novel Immune-Related ceRNA Network and Relative Potential Therapeutic Drug Prediction in ccRCC
por: Li, Weiquan, et al.
Publicado: (2022)

The Variations’ in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis
por: Andrzejczak, Anna, et al.
Publicado: (2023)

Pyroptosis-Related Gene Signature Predicts the Prognosis of ccRCC Using TCGA and Single-Cell RNA Seq Database
por: Gan, Ying, et al.
Publicado: (2022)

Expression of micro-RNAs and genes related to angiogenesis in ccRCC and associations with tumor characteristics
por: Oliveira, Rita de Cássia, et al.
Publicado: (2017)

In-Depth Mapping of the Urinary N-Glycoproteome: Distinct Signatures of ccRCC-related Progression
por: Santorelli, Lucia, et al.
Publicado: (2020)

PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability
por: Chen, Siming, et al.
Publicado: (2021)

Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis
por: Yuan, Lushun, et al.
Publicado: (2018)

Identification and validation of SERPINE1 as a prognostic and immunological biomarker in pan-cancer and in ccRCC
por: Li, Lingqin, et al.
Publicado: (2023)

Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC)
por: Yuan, Lushun, et al.
Publicado: (2017)

Aging-based molecular classification and score system in ccRCC uncovers distinct prognosis, tumor immunogenicity, and treatment sensitivity
por: Zhu, Maoshu, et al.
Publicado: (2022)

An immunotherapy response prediction model derived from proliferative CD4(+) T cells and antigen-presenting monocytes in ccRCC
por: Zheng, Kun, et al.
Publicado: (2022)

Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors
por: Wrzesiński, Tomasz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7jlujvcem37jnttc933leiidoq